Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.
Chemical Structure : PHD inhibitor IOX5
Catalog No.: PC-22353Not For Human Use, Lab Use Only.
IOX5 is a potent, selective HIF-prolyl hydroxylase (PHD) inhibitor with IC50 of 0.15 uM ((PHD2), does not inhibit other 2OG-dependent oxygenases (JMJD6, FIH, KDM6B etc.).
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
IOX5 is a potent, selective HIF-prolyl hydroxylase (PHD) inhibitor with IC50 of 0.15 uM ((PHD2), does not inhibit other 2OG-dependent oxygenases (JMJD6, FIH, KDM6B etc.).
IOX5 shown to compete with 2OG for binding to PHD2, stabilizes HIF-1α at 0.5 μM in HEK293T cells.
IOX5 does not inhibit any of the other tested human 2OG-dependent oxygenases, including FIH and the histone-modifying 2OG oxygenases lysine-specific demethylase 4A (KDM4A), lysine-specific demethylase 5B (KDM5B), lysine-specific demethylase 6B (KDM6B), JMJD6 at 100 μM and the prolyl hydroxylase OGFOD1 at 50 uM.
stabilizes HIF-1α and substantially impacts AML growth and survival in vitro.
IOX5 compromises both MLL-rearranged and non-MLL AML in vivo, decreases AML engraftment and increases survival in vivo but does not affect normal hematopoiesis.
IOX5 compromises AML in a HIF-α dependent manner, requires the intact HIF system to exhibit its anti-leukemic activity.
| M.Wt | 368.36 | |
| Formula | C17H19F3N4O2 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
1. Lawson H, et al. Nat Cancer. 2024 Apr 18. doi: 10.1038/s43018-024-00761-w.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright
